New England Biolabs (NEB), founded in 1974 and headquartered in Ipswich, Massachusetts, USA, is a privately held company dedicated to the research and production of enzyme products for molecular biology. Founded by scientists for scientists, NEB embraces the philosophy of “Scientists for Scientists,” reinvesting its earnings into fundamental research to engage with the scientific community and drive innovation. Restriction endonucleases remain NEB’s most iconic core product line, with over 280 enzymes currently available. At the same time, the company has continuously expanded beyond traditional restriction enzymes, extending its product portfolio to include PCR and amplification technologies, next‑generation sequencing (NGS) library preparation, synthetic biology, RNA analysis and modification, epigenetics, glycobiology, and protein expression and purification. This comprehensive product matrix covers key areas of genomic research, providing global researchers with the widest selection of recombinant and native enzymes.